Tenaya Therapeutics Inc TNYA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/15/24 EDT
4.25quote price arrow down-0.15 (-3.41%)
Volume
328,789
52 week range
1.66 - 8.09
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.25
  • 52 Week High8.09
  • 52 Week High Date06/06/23
  • 52 Week Low1.66
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap333.70M
  • Shares Out78.52M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta2.62
  • YTD % Change31.17

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.25
  • 52 Week High8.09
  • 52 Week High Date06/06/23
  • 52 Week Low1.66
  • 52 Week Low Date10/27/23
  • Market Cap333.70M
  • Shares Out78.52M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta2.62
  • YTD % Change31.17

RATIOS/PROFITABILITY

  • EPS (TTM)-1.65
  • P/E (TTM)-2.58
  • Fwd P/E (NTM)-2.59
  • EBITDA (TTM)-122.463M
  • ROE (TTM)-64.83%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/19/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tenaya Therapeutics Inc

 

Profile

MORE
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an...
David Goeddel Ph.D.
Independent Chairman of the Board
Faraz Ali
Chief Executive Officer, Director
Leone Patterson CPA
Chief Financial and Business Officer
Address
171 Oyster Point Blvd., Suite 500
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
AVIR
Atea Pharmaceuticals Inc
3.71-0.25-6.31%
AVXL
Anavex Life Sciences Corp
4.49+0.18+4.18%
ERAS
Erasca Inc
1.89+0.03+1.61%
NAUT
Nautilus Biotechnology Inc
2.87+0.01+0.35%
BDTX
Black Diamond Therapeutics Inc
5.44-0.30-5.23%